Oral capsule developer Rani Therapeutics files for a $100 million IPO

Rani Therapeutics, which develops ingestible capsules for oral dosing of medication, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Rani Therapeutics is a clinical stage biotherapeutics company advancing technologies to enable the developmRead More